Select Resources

  • Alliance for Balanced Pain Management (AfBPM)
    • A diverse collective of health care advocacy groups, patient organizations, industry representatives and other stakeholders who organize to ensure people with or affected by pain have appropriate access to integrated, effective and safe care across the continuum of care, and raise awareness of the need for individualized treatment.
  • Alliance for Patient Access (AfPA)
    • The Pain Therapy Access Physicians Working Group brings together health care providers with an interest in public policy enabling access to appropriate pain management for patients. The working group develops educational resources, such as white papers, policy briefs and videos, which encourage informed policymaking.
  • National Institute on Drug Abuse (NIDA)
  • Pain & Policy Studies Group (PPSG)
    • A World Health Organization (WHO) collaborating center and global research program at the University of Wisconsin whose mission is to improve global pain relief by achieving balanced access to opioids in an effort to enhance the quality of people living with cancer and other painful diseases.
  • Pain Action Alliance to Implement a National Strategy (PAINS)

Select References

Campbell LC, Robinson K, Meghani SH, Vallerand A, Schatman M, Sonty N. Challenges and opportunities in pain management disparities research: implications for clinical practice, advocacy and policy. J Pain 2012;13(7):611-619. PMID:22560002 PMCID: PMC3958966 DOI:10.1016/j.jpain.2012.02.004

Doelberg CD, Brown RE Jr, Du Vivier D, Meyer JE, Ramachandran BK. The US opioid crisis: current federal and state legal issues. Anesth Analg 2017;125(5):1675-1681. PMID:29049113 DOI: 10.1213/ANE.0000000000002403

Gross J, Gordon DB. The strengths and weaknesses of current US policy to address pain. Am J Public Health 2018 Nov 29:e1-e7. doi: 10.2105/AJPH.2018.304746. [Epub ahead of print].

Kertesz SG, Gordon AJ. A crisis of opioids and the limits of prescription control: United States. Addiction 2019;114(1):169-180. PMID:30039595 DOI:10.1111/add.14394

Tabak RG, Eyler AA, Dodson EQ, Brownson RC. Accessing evidence to inform public health policy: a study to enhance advocacy. Public Health 2015;129(6):698-704. PMID: 25795018 PMCID: PMC4475480 DOI: 10.1016/j.puhe.2015.02.016

Twillman RK, Kirch R, Gilson a. Efforts to control prescription drug abuse: why clinicians should be concerned and take action as essential advocates for rational policy. CA Cancer J Clin 2014;64(6) PMID: 25044063   DOI:10.3322/caac.21243

Ware LJ, Bruckenthal P, Davis GC, O’Conner-Von SK, Factors that influence patient advocacy by pain management nurses: results of the American Society for Pain Management nursing survey, Pain Manag Nurs 2011;12(1):25-32. PMID:21349446 DOI: 10.1016/j.pmn.2009.12.001

Wee Jun Yan I, Lim Tian Ying B, Brennan F. Public policy: an analgesia for opioid diverstion. J Pain Palliat Care Pharmacother 2019;1-14. PMID:30676178 DOI:10.1080/15360288.2018.1546788


  • Jacob Gross MD, MPH
  • Rebecca C. Dale, DO
  • Debra B. Gordon RN, DNP, FAAN
University of Washington logo
University of Washington